Effects of intensive blood pressure control on mortality and cardiorenal function in chronic kidney disease patients

Yong Zhang,Jing-Jing Li,An-Jun Wang,Bo Wang,Shou-Liang Hu,Heng Zhang,Tian Li,Yan-Hong Tuo
DOI: https://doi.org/10.1080/0886022x.2021.1920427
IF: 3.222
2021-01-01
Renal Failure
Abstract:BACKGROUND: Blood pressure (BP) variability is highly correlated with cardiovascular and kidney outcomes in patients with chronic kidney disease (CKD). However, appropriate BP targets in patients with CKD remain uncertain.METHODS: We searched PubMed, Embase, and the Cochrane Library for randomized controlled trials (RCTs) of CKD patients who underwent intensive BP management. Kappa score was used to assess inter-rater agreement. A good agreement between the authors was observed to inter-rater reliability of RCTs selection (kappa = 0.77; <i>P</i> = 0.005).RESULTS: Ten relevant studies involving 20 059 patients were included in the meta-analysis. Overall, intensive BP management may reduce the incidence of cardiovascular disease mortality (RR: 0.69, 95% CI: 0.53 to 0.90, <i>P</i>: 0.01), all-cause mortality (RR: 0.77, 95% CI: 0.67 to 0.88, <i>P</i> &lt; 0.01) and composite cardiovascular events (RR: 0.84 95% CI: 0.75 to 0.95, <i>P</i> &lt; 0.01) in patients with CKD. However, reducing BP has no significant effect on the incidence of doubling of serum creatinine level or 50% reduction in GFR (RR: 1.26, 95% CI: 0.66 to 2.40, <i>P</i> = 0.48), composite renal events (RR 1.07, 95% CI: 0.81 to 1.41, <i>P</i> = 0.64) or SAEs (RR: 0.97, 95% CI: 0.90 to 1.05, <i>P</i> = 0.48).CONCLUSION: In patients with CKD, enhanced BP management is associated with reduced all-cause mortality, cardiovascular mortality, and incidence of composite cardiovascular events.
urology & nephrology
What problem does this paper attempt to address?